Literature DB >> 22923320

In vitro molecular characterization of RNA-proteins interactions during initiation of translation of a wild-type and a mutant Coxsackievirus B3 RNAs.

Amira Souii1, Manel Ben M'hadheb-Gharbi, Mahjoub Aouni, Jawhar Gharbi.   

Abstract

Translation initiation of Coxsackievirus B3 (CVB3) RNA is directed by an internal ribosome entry site (IRES) within the 5' untranslated region. Host cell factors involved in this process include some canonical translation factors and additional RNA-binding proteins. We have, previously, described that the Sabin3-like mutation (U475 → C) introduced in CVB3 genome led to a defective mutant with a serious reduction in translation efficiency. With the aim to identify proteins interacting with CVB3 wild-type and Sabin3-like IRESes and to study interactions between HeLa cell or BHK-21 protein extracts and CVB3 RNAs, UV-cross-linking assays were performed. We have observed a number of proteins that specifically interact with both RNAs. In particular, molecular weights of five of these proteins resemble to those of the eukaryotic translation initiation factors 4G, 3b, 4B, and PTB. According to cross-linking patterns obtained, we have demonstrated a better affinity of CVB3 RNA binding to BHK-21 proteins and a reduced interaction of the mutant RNA with almost cellular polypeptides compared to the wild-type IRES. On the basis of phylogeny of some initiation factors and on the knowledge of the initiation of translation process, we focused on the interaction of both IRESes with eIF3, p100 (eIF4G), and 40S ribosomal subunit by filter-binding assays. We have demonstrated a better affinity of binding to the wild-type CVB3 IRES. Thus, the reduction efficiency of the mutant RNA to bind to cellular proteins involved in the translation initiation could be the reason behind inefficient IRES function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22923320     DOI: 10.1007/s12033-012-9592-x

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  93 in total

Review 1.  Mechanism and regulation of eukaryotic protein synthesis.

Authors:  W C Merrick
Journal:  Microbiol Rev       Date:  1992-06

Review 2.  eIF3: a versatile scaffold for translation initiation complexes.

Authors:  Alan G Hinnebusch
Journal:  Trends Biochem Sci       Date:  2006-08-22       Impact factor: 13.807

3.  Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y.

Authors:  N La Monica; V R Racaniello
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  La autoantigen is required for the internal ribosome entry site-mediated translation of Coxsackievirus B3 RNA.

Authors:  Partho Sarothi Ray; Saumitra Das
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

5.  IRES interaction with translation initiation factors: functional characterization of novel RNA contacts with eIF3, eIF4B, and eIF4GII.

Authors:  S López de Quinto; E Lafuente; E Martínez-Salas
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

6.  Conservation and diversity of eukaryotic translation initiation factor eIF3.

Authors:  K Asano; T G Kinzy; W C Merrick; J W Hershey
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

7.  Molecular analysis of the role of IRES stem-loop V in replicative capacities and translation efficiencies of Coxsackievirus B3 mutants.

Authors:  Manel Ben M'hadheb-Gharbi; Katherine M Kean; Jawhar Gharbi
Journal:  Mol Biol Rep       Date:  2007-11-20       Impact factor: 2.316

8.  La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate.

Authors:  K Meerovitch; Y V Svitkin; H S Lee; F Lejbkowicz; D J Kenan; E K Chan; V I Agol; J D Keene; N Sonenberg
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Foot-and-mouth disease virus infection induces proteolytic cleavage of PTB, eIF3a,b, and PABP RNA-binding proteins.

Authors:  Miguel Rodríguez Pulido; Paula Serrano; Margarita Sáiz; Encarnación Martínez-Salas
Journal:  Virology       Date:  2007-04-18       Impact factor: 3.616

10.  Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.

Authors:  Amorsolo L Suguitan; Josephine McAuliffe; Kimberly L Mills; Hong Jin; Greg Duke; Bin Lu; Catherine J Luke; Brian Murphy; David E Swayne; George Kemble; Kanta Subbarao
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

View more
  5 in total

Review 1.  Role of RNA structure motifs in IRES-dependent translation initiation of the coxsackievirus B3: new insights for developing live-attenuated strains for vaccines and gene therapy.

Authors:  Amira Souii; Manel Ben M'hadheb-Gharbi; Jawhar Gharbi
Journal:  Mol Biotechnol       Date:  2013-10       Impact factor: 2.695

2.  Cellular Proteins Act as Bridge Between 5' and 3' Ends of the Coxsackievirus B3 Mediating Genome Circularization During RNA Translation.

Authors:  Amira Souii; Manel Ben M'hadheb-Gharbi; Jawhar Gharbi
Journal:  Curr Microbiol       Date:  2015-07-03       Impact factor: 2.188

3.  In vitro-reduced translation efficiency of coxsackievirus B3 Sabin3-like strain is correlated to impaired binding of cellular initiation factors to viral IRES RNA.

Authors:  Manel Ben M'hadheb; Amira Souii; Myriam Harrabi; Nadia Jrad-Battikh; Jawhar Gharbi
Journal:  Curr Microbiol       Date:  2015-02-12       Impact factor: 2.188

4.  Molecular Analysis of RNA-RNA Interactions between 5' and 3' Untranslated Regions during the Initiation of Translation of a Cardiovirulent and a Live-Attenuated Coxsackievirus B3 Strains.

Authors:  Amira Souii; Jawhar Gharbi; Manel Ben M'hadheb-Gharbi
Journal:  Int J Mol Sci       Date:  2013-02-25       Impact factor: 5.923

5.  Impaired binding of standard initiation factors eIF3b, eIF4G and eIF4B to domain V of the live-attenuated coxsackievirus B3 Sabin3-like IRES--alternatives for 5'UTR-related cardiovirulence mechanisms.

Authors:  Amira Souii; Jawhar Gharbi; Manel Ben M'hadheb-Gharbi
Journal:  Diagn Pathol       Date:  2013-09-24       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.